Goldman Sachs’s LAVA Medtech Acquisition Corp. Warrants LVACW Stock Holding History

Goldman Sachs’s Portfolio LVACW Stock Details LVACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-128,443	Closed	-$7.08K	–	6257
2023 Q1	$7.08K	Hold	128,443	–	–	﹤0.01%	5770
2022 Q4	$655	Hold	128,443	–	–	﹤0.01%	5914
2022 Q3	$13K	Hold	128,443	–	–	﹤0.01%	6007
2022 Q2	$13K	Hold	128,443	–	–	﹤0.01%	6238
2022 Q1	$45K	Buy	+128,443	New	+$52K	﹤0.01%	6292

Goldman Sachs's LVACW Position: Q2 2023 in Review

Goldman Sachs sold out of LAVA Medtech Acquisition Corp. Warrants (LVACW) in Q2 2023, closing a stake of 128,443 shares — an estimated $7.08K sold.

Goldman Sachs first reported a position in LVACW in Q1 2022 and held it in 5 quarters. The position peaked at $45K in Q1 2022. 0 funds tracked by Wall St. Rank hold LVACW as of Q2 2023.

Goldman Sachs reported no remaining LAVA Medtech Acquisition Corp. Warrants position as of Q2 2023 after selling out during the quarter.
Goldman Sachs sold 128,443 LAVA Medtech Acquisition Corp. Warrants shares in Q2 2023, an estimated $7.08K.
Goldman Sachs first reported a position in LAVA Medtech Acquisition Corp. Warrants in Q1 2022 and held it in 5 quarters.
Goldman Sachs's LAVA Medtech Acquisition Corp. Warrants position peaked at $45K in Q1 2022.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Warrants as of Q2 2023.

Based on Goldman Sachs's 13F filing for Q2 2023, filed 15 Aug 2023.